ENBREL FDA APPROVED FOR EXPANDED INDICATION

The FDA approved Amgen and Wyeth Pharmaceuticals drug, Enbrel (etanercept), to inhibit the progression of structural damage in patients with active psoriatic arthritis and reduce its signs and symptoms.

Related Videos
Related Content

Indoor Tanning and Melanoma

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Tips to Organize the Digital Chaos with Alina Bridges, DO

March 20th 2023

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023

Indoor Tanning and Melanoma

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Tips to Organize the Digital Chaos with Alina Bridges, DO

March 20th 2023

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023

Indoor Tanning and Melanoma

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Tips to Organize the Digital Chaos with Alina Bridges, DO

March 20th 2023

Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.